Lupin’s arm recalling 39,216 bottles of Lisinopril & Hydrochlorothiazide tablets from US
26th Aug 2019

Lupin’s American subsidiary -- Lupin Pharmaceuticals Inc is recalling 39,216 bottles of Lisinopril and Hydrochlorothiazide tablets USP, 10 mg/12.5 mg, 100 tablet bottle manufactured at its Pithampur facility from the US market. The reason for the recall is presence of foreign substance; product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles. The tablets are used for treatment of hypertension.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.